ImageneBio, Inc. (NASDAQ:IMA) Receives Consensus Rating of "Hold" from Brokerages
MarketBeat
ImageneBio, Inc. (NASDAQ:IMA - Get Free Report) has been assigned a consensus recommendation of "Hold" from the five research firms that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating, one has
NASDAQ:IMA